Abstract 4367364: A Multicenter Friedreich Ataxia Registry Identifies Posterior Wall Thickness as a Predictor of Major Adverse Cardiac Events

K Kimberly Lin (Children’s Hospital of Philadelphia, Philadelphia) A Anna Dedio (Childrens Hospital of Philadelphia, Swarthmore, Pennsylvania, United States) K Kara McSweeney (Childrens Hospital of Philadelphia, Swarthmore, Pennsylvania, United States) A Anne Fournier (Division of Pediatric Cardiology, CHU Sante-Justine, Universite de Montreal, Montreal QC, Canada (A.F.)) G Grace Yoon (Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada) R Ronald Payne (Indiana Univ. School of Medicine, Zionsville, Indiana, United States) L Linda Cripe (Nationwide Children's Hospital, Columbus, Ohio, United States) A Aarti Patel (University of South Florida, Tampa, Florida, United States) T Talha Niaz (Mayo Clinic, Rochester, Minnesota, United States) J Jonathan Johnson (Mayo Clinic, Rochester, Minnesota, United States) S Shana McCormack (Childrens Hospital of Philadelphia, Swarthmore, Pennsylvania, United States) D David Lynch B Barbara Tate (Friedreich Ataxia Research Alliance, Downingtown, Pennsylvania, United States) Y Yixuan Feng J Jing Huang L Laura Mercer-Rosa

Abstract

Background: Cardiac disease is the leading cause of premature mortality in Friedreich Ataxia (FA). However, validated prognostic indicators or early imaging biomarkers that can reliably predict cardiac events are lacking. To address this gap, we created a multicenter FA cardiac registry to characterize disease progression and identify early echocardiographic (echo) predictors of major adverse cardiac events (MACE). Methods: FA subjects from 6 North American centers with at least two echos performed ≥5 years apart were included. Demographics, FA-specific disease characteristics, and MACE (a composite of death, heart failure hospitalization, aborted sudden cardiac death, and/or life-threatening arrhythmia) were abstracted. Digital echo images were re-read at a centralized core lab. Paired T tests were utilized for comparison of the normally distributed first and second echo parameters, and logistic regression models were utilized to evaluate for predictors of MACE. Results: Of 115 subjects, 52 (45%) were female. Mean age at diagnosis was 10 ± 3 years, median GAA1 repeat length (a marker of genetic severity) was 700 (range 66–1200), and median age at first analyzed echo was 12 years (range 4-36). MACE occurred in 35 (30%) of the cohort. Serial echocardiograms demonstrated progressive worsening of multiple cardiac parameters over time, including markers of ventricular thickness and hypertrophy, chamber size, systolic function, and novel markers of atrial and ventricular strain (Table 1). On univariate analysis, several markers of hypertrophy and systolic function from the earliest analyzed echo predicted MACE. However, after adjusting for age of diagnosis, GAA1 repeat length, and collinearity among variables, only posterior wall thickness in diastole (PWTd) remained an independent predictor of MACE (odds ratio 1.8 per mm increase, 95% CI 1.1–3.3, p = 0.028). Conclusions: This multicenter FA registry identifies early posterior wall thickness as a significant and independent predictor of major adverse cardiac events in FA. Each millimeter increase in PWTd on early echo is associated with nearly double the odds of MACE. This commonly acquired parameter is often overlooked and may serve as a powerful early marker of cardiac risk. Further investigation of PWTd as a potential surrogate endpoint for therapeutic trials in FA is warranted.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (16)

K

Kimberly Lin

Children’s Hospital of Philadelphia, Philadelphia

A

Anna Dedio

Childrens Hospital of Philadelphia, Swarthmore, Pennsylvania, United States

K

Kara McSweeney

Childrens Hospital of Philadelphia, Swarthmore, Pennsylvania, United States

A

Anne Fournier

Division of Pediatric Cardiology, CHU Sante-Justine, Universite de Montreal, Montreal QC, Canada (A.F.)

G

Grace Yoon

Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

R

Ronald Payne

Indiana Univ. School of Medicine, Zionsville, Indiana, United States

L

Linda Cripe

Nationwide Children's Hospital, Columbus, Ohio, United States

A

Aarti Patel

University of South Florida, Tampa, Florida, United States

T

Talha Niaz

Mayo Clinic, Rochester, Minnesota, United States

J

Jonathan Johnson

Mayo Clinic, Rochester, Minnesota, United States

S

Shana McCormack

Childrens Hospital of Philadelphia, Swarthmore, Pennsylvania, United States

D

David Lynch

B

Barbara Tate

Friedreich Ataxia Research Alliance, Downingtown, Pennsylvania, United States

Y

Yixuan Feng

J

Jing Huang

L

Laura Mercer-Rosa